How does ABT's Q3 2024 surprise impact investors?

Abbott Laboratories' (ABT) Q3 2024 earnings per share (EPS) surprise of $0.01, along with a percentage change of 3.74%, has a positive impact on investors, as it indicates the company's performance exceeded expectations:

|code|Ticker|Name|Date|Percentage Change|EPS Surprise|market_code|
|---|---|---|---|---|---|---|
|ABT|ABT.N|Abbott Laboratories|20231002|-1.1564||169|
|ABT|ABT.N|Abbott Laboratories|20231003|0.0627||169|
|ABT|ABT.N|Abbott Laboratories|20231004|-0.1462||169|
|ABT|ABT.N|Abbott Laboratories|20231005|0.575||169|
|ABT|ABT.N|Abbott Laboratories|20231006|0.7069||169|
|ABT|ABT.N|Abbott Laboratories|20231009|-0.1239||169|
|ABT|ABT.N|Abbott Laboratories|20231010|0.8268||169|
|ABT|ABT.N|Abbott Laboratories|20231011|-5.0431||169|
|ABT|ABT.N|Abbott Laboratories|20231012|-2.6446||169|
|ABT|ABT.N|Abbott Laboratories|20231013|0.754||169|